Validation of RespiLife for Detection of Respiratory Suppression

Completed · Not applicable

Conditions studied: Respiration Disorders

In brief

The purpose of this study is to evaluate the accuracy of RespiLife diagnostic technology for detection of respiratory rate and oxygen saturation in human subjects. This includes evaluation of Bioresp's RespiLife and its accuracy for measurement of respiratory rate and oxygen saturation.

Key facts

Study ID

NCT03819023

Run by

Bioresp Technologies, Inc.

People needed

30

Starts

2018-12-20

Expected to finish

2019-03-20

Last updated by the study team

2019-04-04

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Able to understand and sign the informed consent
• English speaking.
• Able to comply with visits and follow ups included in this protocol
• Ages 18-80 years

You may not qualify if…

• Mentally or cognitively incompetent persons who cannot understand the procedures or consent to the procedures.
• An unstable medical condition, acute of chronic, that in the opinion of the investigator puts the subject at health risks related this trial or interferes with the clinical trial and data collection.
• If a subject is not able to stop his CPAP or BiPAP therapy at least one week prior to the sleep study night. This will be determined ty the principal investigator based on her judgment.
• Skin rash on the forehead.
• A history of skin allergy to medical tape, even hypoallergenic tape.
• A history of skin cancer on the forehead.

Where it is running

• Peninsula Sleep Center — Burlingame, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.